Microdosing GLP-1
Starting at $149/month
LIMITED TIME: Save up to $30 on your first month
Microdosing GLP-1
(Injectable) for Longevity
Starting at $149/month
A low-dose GLP-1 designed to work in sync with your body to minimize side effects and promote long-term wellness.*
79%
saw at least one improvement after their second check-in
What is Microdosing GLP-1?
GLP-1 medications may activate key biological pathways that support longevity¹ ². Taking smaller (micro) doses may also lower the risk of side effects⁴, creating a harmony with your body's natural processes that may help you live healthier, longer.**
Microdosing GLP-1 Benefits
Do More, Age Less
May improve mitochondrial function and oxidative stress²
Low doses may reduce side effects⁴
Do More, Age Less
B12/MIC INJECTION BENEFITS
Feel energized while fighting off fatigue
Ignite your metabolism to support weight loss goals
Enhance your mental clarity, focus & memory
Support your liver to flush out toxins & naturally detox your body
Maintain the connections between neurons (called synapses) to potentially offset the risk of Alzheimer’s*
Why Microdosing GLP-1 matters for longevity
Supports Longevity: May activate biological pathways that extend GLP-1 benefits beyond weight loss to enhance overall healthspan¹ ².
What AgelessRx customers are saying
The above testimonials are from real AgelessRx customers sourced from Trustpilot.com. Your individual results might differ from the above testimonials. Testimonials are not a guarantee of future results.
Slowing aging has never been simpler
Explore our treatments
Browse our offerings or tell us about your health goals.
Pause or cancel anytime
Plus, enjoy ongoing support from our world-class care team.
Get medical review
Fill out a brief intake form and receive a response in 2-3 days.
Enjoy fast, free shipping
Orders are delivered anywhere in the US within 5-7 business days.
Get access to cutting edge longevity treatments without leaving the couch
IMPORTANT SAFETY INFORMATION & COMMON SIDE EFFECTS
Microdosing GLP-1 should be used with a reduced-calorie meal plan and increased physical activity.
Do not use with other GLP-1 receptor agonist medications, or any other products containing Semaglutide.
Side effects
Microdosing GLP-1 is a low-dose Oral Semaglutide or Injectable Semaglutide prescription.
Neither Oral Semaglutide nor Injectable Semaglutide have been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder).
Common side effects normally go away on their own within a few days or up to 2-3 weeks. Read our blog for more tips on how to manage Semaglutide side effects. If you find that any side effects persist for longer than this or get worse over time, stop taking your medication and contact your prescriber as soon as possible.
For a full list of side effects, please review the Mayo Clinic’s GLP-1 resources.
Other important safety information
Do not use GLP-1 if you have a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis.
The FDA is currently evaluating whether GLP-1 medications may increase the risk of suicidal thoughts or actions. Though the FDA has found no evidence supporting this risk, patients with a history of suicidal thoughts should not take GLP-1 medications.
Do not use GLP-1 if you are pregnant or breastfeeding, or planning to become pregnant or breastfeed.
Though rare, allergic reactions to GLP-1 medications are possible. If you notice any shortness of breath or swelling around your face, tongue, or throat after using GLP-1, stop using the medication immediately and contact emergency services right away.
As with any prescription medicine, the dose prescribed is for you and you alone. Do not, under any circumstances, allow anyone else to use your prescription.
Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you are taking any medications to treat diabetes, including sylfonylureas or insulin.
Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not Microdosing GLP-1 is appropriate for you.
IMPORTANT SAFETY INFORMATION & COMMON SIDE EFFECTS
Copyright 2025 by AgelessRx
OUR OFFERINGS
LEARN
CONTACT US
Not Sure if Microdosing GLP-1 is Right For You?
FREE Personalized Wellness & Longevity Report
Get a picture of your longevity outlook & receive personalized recommendations to help you reach your goals.
Compounded Semaglutide
Starting at $290/month
LIMITED TIME: Save up to $30 on your first month
Microdosing GLP-1
for Longevity
Starting at $149/month
A low-dose GLP-1 designed to work in sync with your body to minimize side effects and promote long-term wellness.*
saw at least one improvement after their first check-in*
79%
GLP-1 medications may activate key biological pathways that support longevity¹ ². Taking smaller (micro) doses may also lower the risk of side effects⁴, creating a harmony with your body's natural processes that may help you live healthier, longer.**
What is Microdosing GLP-1?
May modulate inflammatory pathways¹
May reduce risk of cognitive decline²
May support cardiovascular health³
May improve mitochondrial function and oxidative stress²
Low doses may reduce side effects⁴
Microdosing GLP-1 Benefits
Supports Longevity
May activate biological pathways that extend GLP-1 benefits beyond weight loss to enhance overall healthspan¹ ².
Reduces Cognitive Decline
May reduce the risk of age-related cognitive decline and dysfunction².
Stifles Inflammation
May target chronic inflammation to support joint health and reduce pain¹.
Combats Age-Related Diseases
May trigger molecular pathways that help prevent conditions like heart disease, neurodegeneration, and metabolic disorders² ³.
Why Microdosing GLP-1 matters for longevity
What AgelessRx customers
are saying
The above testimonials are from real AgelessRx customers sourced from Trustpilot.com. Your individual results might differ from the above testimonials. Testimonials are not a guarantee of future results.
Slowing aging has never been simpler
Explore our treatments
Browse our offerings or tell us about your health goals.
Pause or cancel anytime
Plus, enjoy ongoing support from our world-class care team.
Get medical review
Fill out a brief intake form and receive a prescriber response in 2-3 days.
Enjoy fast, free shipping
Orders are delivered anywhere in the US within 5-7 business days.
Get access to cutting edge longevity treatments without leaving the couch
*See studies cited below.
**AgelessRx’s compounded Oral Semaglutide Drops have not been reviewed or approved by the FDA or analyzed by any available scientific study. However, our medical experts expect that Microdosing GLP-1 Oral Semaglutide Drops may sustain many of the same benefits that low doses of Semaglutide-based injection medications have shown individually in the studies cited above.
¹J Clin Tran Endo, 2024. This review study analyzes human GLP-1 trials, including protocols via injection that may be considered low dose or microdosing.
²Aging and Disease, 2022. This review study analyzes human and animal trials of various GLP-1 medications for their role in addressing the hallmarks of aging, such as mitochondrial function and oxidative stress, including low-dose protocols via injection for Parkinson's patients on exenatide.
³NEJM, 2016. The SUSTAIN 6 clinical trial, sponsored by Novo Nordisk, explores cardiovascular outcomes for patients taking Semaglutide injections at doses as low as 0.5mg.
⁴JAMA Network, 2022. A human trial analyzing patients on Semaglutide injections that shows patients who stopped at lower doses of GLP-1 medications experienced less side effects.
*See studies cited below.
**AgelessRx’s compounded Oral Semaglutide Drops have not been reviewed or approved by the FDA or analyzed by any available scientific study. However, our medical experts expect that Microdosing GLP-1 Oral Semaglutide Drops may sustain many of the same benefits that low doses of Semaglutide-based injection medications have shown individually in the studies cited above.
¹J Clin Tran Endo, 2024. This review study analyzes human GLP-1 trials, including protocols via injection that may be considered low dose or microdosing.
²Aging and Disease, 2022. This review study analyzes human and animal trials of various GLP-1 medications for their role in addressing the hallmarks of aging, such as mitochondrial function and oxidative stress, including low-dose protocols via injection for Parkinson's patients on exenatide.
³NEJM, 2016. The SUSTAIN 6 clinical trial, sponsored by Novo Nordisk, explores cardiovascular outcomes for patients taking Semaglutide injections at doses as low as 0.5mg.
⁴JAMA Network, 2022. A human trial analyzing patients on Semaglutide injections that shows patients who stopped at lower doses of GLP-1 medications experienced less side effects.
Reduces Cognitive Decline: May reduce the risk of age-related cognitive decline and dysfunction².
Stifles Inflammation: May target chronic inflammation to support joint health and reduce pain¹.
Combats Age-Related Diseases: May trigger molecular pathways that help prevent conditions like heart disease, neurodegeneration, and metabolic disorders² ³.
¹J Clin Tran Endo, 2024. This review study analyzes human GLP-1 trials, including protocols via injection that may be considered low dose or microdosing.
²Aging and Disease, 2022. This review study analyzes human and animal trials of various GLP-1 medications for their role in addressing the hallmarks of aging, such as mitochondrial function and oxidative stress, including low-dose protocols via injection for Parkinson's patients on exenatide.
³NEJM, 2016. The SUSTAIN 6 clinical trial, sponsored by Novo Nordisk, explores cardiovascular outcomes for patients taking Semaglutide injections at doses as low as 0.5mg.
J Clin Tran Endo, 2024. This review study analyzes human GLP-1 trials, including protocols via injection that may be considered low dose or microdosing.
²Aging and Disease, 2022. This review study analyzes human and animal trials of various GLP-1 medications for their role in addressing the hallmarks of aging, such as mitochondrial function and oxidative stress, including low-dose protocols via injection for Parkinson's patients on exenatide.
³NEJM, 2016. The SUSTAIN 6 clinical trial, sponsored by Novo Nordisk, explores cardiovascular outcomes for patients taking Semaglutide injections at doses as low as 0.5mg.
Microdosing GLP-1 (Injectable)
Free shipping | Billed monthly
Your monthly prescription includes:
Coupon automatically applied at checkout for monthly recurring subscriptions. Not available for one-time orders.
Microdosing GLP-1 (Injectable) is not available in AL, AR, KS, LA, MN, MS, NC, OR, and WV.
Starting at
$149/month
Microdosing GLP-1 (Injectable)
Free shipping | Billed monthly
Your monthly prescription includes:
Coupon automatically applied at checkout for monthly recurring subscriptions. Not available for one-time orders.
Microdosing GLP-1 (Oral) is not available in AL, AR, MS, and VA.
Starting at
$149/month